###begin article-title 0
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 108 112 <span type="species:ncbi:10090">Mice</span>
Protective Effects of PARP-1 Knockout on Dyslipidemia-Induced Autonomic and Vascular Dysfunction in ApoE-/- Mice: Effects on eNOS and Oxidative Stress
###end article-title 0
###begin p 1
Conceived and designed the experiments: CPH YF EDL HAB. Performed the experiments: CPH YF AN MZ BR HX. Analyzed the data: CPH YF AN HX KM EDL HAB. Contributed reagents/materials/analysis tools: CPH YF AN EDL HAB. Wrote the paper: CPH YF ADK EDL HAB.
###end p 1
###begin p 2
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 212 215 212 215 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8722;/&#8722;</sup></bold>
###xml 574 577 574 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
The aims of this study were to investigate the role of poly(ADP-ribose) polymerase (PARP)-1 in dyslipidemia-associated vascular dysfunction as well as autonomic nervous system dysregulation. Apolipoprotein (ApoE)-/- mice fed a high-fat diet were used as a model of atherosclerosis. Vascular and autonomic functions were measured in conscious mice using telemetry. The study revealed that PARP-1 plays an important role in dyslipidemia-associated vascular and autonomic dysfunction. Inhibition of this enzyme by gene knockout partially restored baroreflex sensitivity in ApoE-/- mice without affecting baseline heart-rate and arterial pressure, and also improved heart-rate responses following selective blockade of the autonomic nervous system. The protective effect of PARP-1 gene deletion against dyslipidemia-induced endothelial dysfunction was associated with preservation of eNOS activity. Dyslipidemia induced PARP-1 activation was accompanied by oxidative tissue damage, as evidenced by increased expression of iNOS and subsequent protein nitration. PARP-1 gene deletion reversed these effects, suggesting that PARP-1 may contribute to vascular and autonomic pathologies by promoting oxidative tissue injury. Further, inhibition of this oxidative damage may account for protective effects of PARP-1 gene deletion on vascular and autonomic functions. This study demonstrates that PARP-1 participates in dyslipidemia-mediated dysregulation of the autonomic nervous system and that PARP-1 gene deletion normalizes autonomic and vascular dysfunctions. Maintenance of eNOS activity may be associated with the protective effect of PARP-1 gene deletion against dyslipidemia-induced endothelial dysfunction.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Libby1">[1]</xref>
###xml 200 203 200 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Russell1">[2]</xref>
###xml 409 412 409 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Libby1">[1]</xref>
###xml 414 417 414 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Russell1">[2]</xref>
###xml 419 422 419 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Jessani1">[3]</xref>
###xml 705 708 705 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Bishop1">[4]</xref>
###xml 890 893 890 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-LaRovere1">[5]</xref>
###xml 895 898 895 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Lai1">[6]</xref>
###xml 1024 1027 1024 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Lai1">[6]</xref>
###xml 1029 1032 1029 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Guyenet1">[7]</xref>
Atherosclerosis, a major contributor to morbidity and mortality in developed countries, is the underlying cause of a number of cardiovascular diseases and is closely associated with dyslipidemia [1], [2]. Significant research has demonstrated that lipid-associated disorders, such as atherosclerosis, are linked to alterations in hemodynamic parameters, which may result in pathological cardiovascular events [1], [2], [3]. Hypertension and dyslipidemia are mechanistically linked and may act in synergy at the arterial wall to enhance atherogenesis. The autonomic nervous system serves as the main regulator of blood pressure and heart rate homeostasis, in part, by modulation of the arterial baroreflex [4]. Indeed, reduced spontaneous baroreflex sensitivity (SBRS) is associated with impaired cardiac autonomic balance in hypertension, coronary artery disease, and myocardial infarction [5], [6]. In addition, disruption in the balance between parasympathetic and sympathetic tones can lead to cardiovascular dysfunction [6], [7].
###end p 4
###begin p 5
###xml 89 92 89 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Anderson1">[8]</xref>
###xml 641 642 641 642 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 643 644 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 646 649 646 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Kukreja1">[9]</xref>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Braam1">[10]</xref>
###xml 839 842 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 848 852 848 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Wang1">[11]</xref>
###xml 854 858 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Kawashima1">[12]</xref>
###xml 941 945 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Crauwels1">[13]</xref>
###xml 972 976 972 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Liao1">[14]</xref>
###xml 785 791 <span type="species:ncbi:9606">humans</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 1015 1019 <span type="species:ncbi:10090">mice</span>
Endothelial dysfunction has been shown to be a reliable early marker for atherosclerosis [8]. Nitric oxide (NO), a product of endothelial NO synthase (eNOS), is released by the vascular endothelium in response to various stimuli including acethylcholine (Ach), and plays an important role in endothelium-dependent vasodilation. Molecular mechanisms responsible for endothelial dysfunction may include decreased expression of eNOS protein, alterations in the membrane signaling pathway leading to eNOS enzymatic activation (e.g., signaling-induced eNOS phosphorylation), and decreased NO bioavailability through oxidants such as superoxide (O2.-) [9], [10]. Numerous studies have demonstrated that hypercholesterolemia is associated with defects in NO-dependent endothelial function in humans and in many experimental models, including ApoE-/- mice [11], [12]. Impaired endothelium-dependent relaxation in response to ACh occurs in the aorta [13] and the coronary arteries [14] of genetically-altered hyperlipidemic mice.
###end p 5
###begin p 6
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OumounaBenachour1">[15]</xref>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OumounaBenachour1">[15]</xref>
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Hans1">[16]</xref>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Hans2">[17]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OumounaBenachour1">[15]</xref>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Hans2">[17]</xref>
###xml 769 773 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-vonLukowicz1">[18]</xref>
Our laboratory recently demonstrated that poly-ADP-ribose polymerase (PARP)-1 is activated within atherosclerotic plaques in an animal model of atherosclerosis [15]. Indeed, decreasing PARP-1 activity not only led to plaque stability, but actually promoted regression of pre-established atherosclerotic plaques [15], [16], [17]. These anti-atherogenic effects were associated with a reduction in inflammatory factors such as TNF, ICAM, monocyte chemoattractant protein (MCP-1). Additional effects include cellular changes related to plaque dynamics such as an increase in smooth muscle cell (SMC) content, decreased collagen degradation, and increased TIMP-2 expression [15], [17]. Support for these observations is provided by a recent report by von Lukowicz et et al [18].
###end p 6
###begin p 7
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Pacher1">[19]</xref>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Pacher2">[20]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Soriano1">[21]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Szabo1">[22]</xref>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Pacher1">[19]</xref>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Pacher2">[20]</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Gero1">[23]</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Benko1">[24]</xref>
Previous studies have demonstrated that PARP-1 activation might be involved in vascular dysfunction associated with circulatory shock, heart failure, ischemia reperfusion injury, hypertension, and diabetes [19], [20], [21], [22]. Inhibition of PARP-1 confers protection against many of these conditions [19], [20], [23], [24]. However, the exact mechanism by which PARP-1 mediates development of these diseases needs to be better clarified in order for PARP-1 inhibition to be a potential target as a viable therapeutic strategy for cardiovascular disorders.
###end p 7
###begin p 8
In the present study, we used an integrative approach to assess the role of PARP-1 in the pathogenesis of atherosclerosis-associated vascular dysfunction and to investigate the effect of PARP-1 gene knockout on autonomic function and endothelium dysfunction. We also examined the relationship between occurrence of oxidative stress in our experimental model and PARP-1 activation as a potential mechanism for the manifestation of dyslipidemia-associated vascular and autonomic nervous system dysfunction.
###end p 8
###begin title 9
Materials and Methods
###end title 9
###begin title 10
###xml 47 51 <span type="species:ncbi:10090">Mice</span>
Generation of PARP-1 and Double Knockout (DKO) Mice on C57BL/6 Background
###end title 10
###begin p 11
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 338 341 338 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Oumouna1">[25]</xref>
###xml 450 453 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OumounaBenachour1">[15]</xref>
###xml 549 552 549 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 545 760 545 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE<sup>&#8722;/&#8722;</sup> mice fed a HF diet were used as a disease model for the present studies because of the pathogenesis of autonomic and vascular dysfunctions in these mice mimics that found in humans on a very short time-scale</italic>
###xml 761 763 761 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</italic>
###xml 760 764 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Wang1">[<italic>11</italic>]</xref>
###xml 764 765 764 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 216 221 <span type="species:ncbi:10090">mouse</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
###xml 727 733 <span type="species:ncbi:9606">humans</span>
C57BL/6 wild-type, ApoE-/- (Jackson Laboratories, Bar Harbor, ME, USA), and PARP-1-/- mice were housed and bred in a pathogen-free animal care facility at LSUHSC (New Orleans, LA) and allowed full access to standard mouse chow and water. All experimental protocols were approved by the LSUHSC Animal Care and Use Committee. C57BL/6 PARP-1-/- mice were generated as described[25]. DKO mice were generated by crossing PARP-1 heterozygous mice with ApoE-/- mice, as described [15]. All animals were genotyped using polymerase chain reaction (PCR). ApoE-/- mice fed a HF diet were used as a disease model for the present studies because of the pathogenesis of autonomic and vascular dysfunctions in these mice mimics that found in humans on a very short time-scale[11].
###end p 11
###begin title 12
Hemodynamic Parameters
###end title 12
###begin p 13
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 336 0 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4&#8211;6 weeks old male ApoE<sup>&#8722;/&#8722;</sup> and DKO mice (n&#8202;=&#8202;6) were fed regular diet (RD) or high-fat diet (HF; Harlan Teklad, Madison, Wis) containing 21% fat by weight (0.2% cholesterol) for 16 weeks for histological studies. The fat contents of the diet are manipulated to induce changes that are linked to risk of cardiovascular disease in humans.</italic>
###xml 355 358 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Feng1">[26]</xref>
###xml 846 850 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Parati1">[27]</xref>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 329 335 <span type="species:ncbi:9606">humans</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
4-6 weeks old male ApoE-/- and DKO mice (n = 6) were fed regular diet (RD) or high-fat diet (HF; Harlan Teklad, Madison, Wis) containing 21% fat by weight (0.2% cholesterol) for 16 weeks for histological studies. The fat contents of the diet are manipulated to induce changes that are linked to risk of cardiovascular disease in humans. Separate male ApoE-/- and DKO mice (n = 6) were fed under same diet regimen and anesthetized and implanted with a radiotelemetry probe as described[26]. Upon recovery from surgery (approximately1 wk), blood pressure (BP) was recorded during 48 hours to determine baseline hemodynamic parameters (i.e. systolic and diastolic BP, mean arterial pressure (MAP) and heart rate (HR)). From baseline recordings, spontaneous baroreceptor reflex sensitivity (SBRS) was calculated using the sequence method as described[27]. Briefly, from previous BP and HR recordings, all up (increase in BP and decrease in HR) and down (decrease in BP and increase in HR) baroreflex sequences were detected using Hemolab software () and the average SBRS was calculated.
###end p 13
###begin p 14
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Autonomic function</italic>
###xml 566 570 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Xia1">[28]</xref>
Autonomic function was assessed using a pharmacological method involving intraperitoneal injection (i.p.) of a beta-blocker (propranolol, 8 mg/kg), a muscarinic receptor blocker (atropine, 1 mg/kg), or a ganglionic blocker (hexamethonium, 20 mg/kg). All drugs and doses were chosen for their ability to effectively block the respective receptors. Additionally, vascular function was assessed with acetylcholine (ACh; 2 mg/kg) and sodium nitroprusside (1 mg/kg; Sigma Chemicals). Changes in HR were analyzed 30 min after administration of the antagonists as described[28].
###end p 14
###begin title 15
Lipid profile, Histology, Immunohistochemistry, and Immunoblot Analysis
###end title 15
###begin p 16
###xml 449 453 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OumounaBenachour1">[15]</xref>
###xml 567 571 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OumounaBenachour1">[15]</xref>
###xml 573 577 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Hans1">[16]</xref>
###xml 908 912 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Zheng1">[29]</xref>
For lipid profile, animals were fasted for 4 h and samples were sent blindly to Cardiovascular Specialty Laboratories, Inc (Atlanta, GA) for lipid assessment. Perfusion fixed aortas from various genotypes were dissected and prepared for either Oil-Red-O staining using standard protocol or paraffin embedding. Tissues were sectioned (5 microm), subjected to hematoxylin and eosin (H&E) or trichrome staining. Lesion areas were assessed as described [15]. Hearts were paraffin embedded and sections were subjected to immunohistochemistry (IHC) using standard protocols[15], [16] and processed for eNOS (Cell Signal, Danvers, MA), phosphorylated eNOS (Sigma, St. Louis, MO), nitrotyrosine (Upstate, Lake Placid, NY), or iNOS (BD Bioscience, San Jose, CA) detection. Immunoblot analysis of protein extracts prepared from left ventricle of the different experimental groups was conducted as previously described [29]. Antibodies to eNOS or its phosphorylated form were used to probe nitrocellulose membranes.
###end p 16
###begin title 17
Real time PCR
###end title 17
###begin p 18
###xml 151 170 151 170 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CAACGCTACCACGAGGACA</named-content>
###xml 181 202 181 202 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCCTGCAAAGAAAAGCTCTG</named-content>
###xml 277 281 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OumounaBenachour1">[15]</xref>
RNA was extracted from left ventricle using the RNeasy Fibrous Tissue Mini Kit (Qiagen, Valencia, CA). Primers used for eNOS were as follows: forward, CAACGCTACCACGAGGACA; reverse: CTCCTGCAAAGAAAAGCTCTG from Sigma Genosys. (St. Louis, MO). The beta-actin primers were described[15]. Amplification, detection and data analysis were performed using iCycler real-time PCR system (Bio-Rad Laboratories, Hercules, CA, USA).
###end p 18
###begin title 19
Statistical Analysis
###end title 19
###begin p 20
###xml 266 547 264 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Immunohistochemistry data represent arbitrary density units calculated using Pro-Image software and were summarized as a percent of basal control. For the comparison between the same groups on different diet regimen, one way ANOVA was employed to calculate statistical differences.</italic>
###xml 591 592 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Results are expressed as mean+/-SEM, from at least six mice per group unless stated otherwise. Two way or one-way ANOVA for repeated measures, followed by post hoc test, were performed when appropriate using GraphPad Prism 5 (GraphPad Software, San Diego, CA, USA). Immunohistochemistry data represent arbitrary density units calculated using Pro-Image software and were summarized as a percent of basal control. For the comparison between the same groups on different diet regimen, one way ANOVA was employed to calculate statistical differences. Differences were considered significant at P<0.05.
###end p 20
###begin title 21
Results
###end title 21
###begin title 22
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 99 103 <span type="species:ncbi:10090">Mice</span>
PARP-1 Gene Deletion Reduces Atherosclerotic Lesion Formation in High Fat Diet-Fed C57Bl/6 ApoE-/- Mice
###end title 22
###begin p 23
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 242 249 242 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en-face</italic>
###xml 477 486 477 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g001">Figure 1A</xref>
###xml 652 664 652 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g001">Figure 1A, B</xref>
###xml 790 793 790 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 858 861 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 982 991 982 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g001">Figure 1A</xref>
###xml 1163 1167 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OumounaBenachour1">[15]</xref>
###xml 1205 1209 1205 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-vonLukowicz1">[18]</xref>
###xml 1222 1225 1222 1225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 84 90 <span type="species:ncbi:10090">murine</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
###xml 862 866 <span type="species:ncbi:10090">mice</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
###xml 1226 1230 <span type="species:ncbi:10090">mice</span>
In order to verify that PARP-1 gene deletion protects against plaque formation in a murine model of atherosclerosis, aortas were collected from ApoE-/- or DKO mice after a 16-week regimen with regular (RD) or high-fat (HF) diet. As expected, en-face oil red 'O' staining of longitudinally cut aortas revealed that HF diet induces numerous atherosclerotic plaques not only at the brachiocephalic or curvature areas of the thoracic region, but also all over the abdominal aorta (Figure 1A). PARP-1 gene deletion markedly lowered the incidence of these lesions along the aorta in HF fed mice, but this decrease was most prominent in the abdominal region (Figure 1A, B). Moreover, PARP-1 gene deletion not only significantly decreased plaque size but also plaque number (in parentheses) in ApoE-/- mice fed HF diet for 16 weeks. It is important to note that ApoE-/- mice fed RD for 16 weeks, developed few fatty streaks that were comparable to those observed in their DKO counterparts (Figure 1A). These results are consistent with previous observations from our laboratory using pharmacological inhibitor or heterozygous mice for PARP-1 on C57BL/6 genetic background[15] and findings from von Lukowicz et al [18] using PARP-1-/- mice on a mixed genetic background.
###end p 23
###begin title 24
PARP-1 gene deletion promotes atherosclerotic plaque reduction in an animal model of atherosclerosis.
###end title 24
###begin p 25
###xml 126 133 126 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en face</italic>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OumounaBenachour1">[15]</xref>
###xml 248 249 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 311 314 306 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
(A) Aortas from the different experimental groups were formalin (PBS)-perfused and atherosclerotic plaques were visualized by en face Oil-Red-O staining. (B) Quantitation of plaque size and number (in parentheses) were determined as described[15]; P value (<0.05) *compared to ApoE-/- RD, daggercompared to ApoE-/- HF (16 weeks), and double daggercompared to DKO mice on RD.
###end p 25
###begin title 26
Lack of PARP-1 Improves Baroreflex Sensitivity without Affecting Baseline Hemodynamic Parameters
###end title 26
###begin p 27
###xml 224 233 224 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g002">Figure 2A</xref>
###xml 239 242 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Lazartigues1">[30]</xref>
###xml 634 649 634 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g002">Figure 2B and C</xref>
###xml 144 148 <span type="species:ncbi:10090">Mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
One week prior to the completion of the diet regimens, the different experimental groups were implanted with telemetry probes for BP recording. Mice were then allowed to recover for one week before measurements. As shown in Figure 2A, ApoE-/- mice on RD show a significant reduction of SBRS consistent with our previous observations[30]. PARP-1 gene deletion restored baroreflex sensitivity in these mice. This reversal was completely absent in HF-diet treated mice. Baseline heart rate (HR) and mean arterial pressure (MAP) did not significantly differ between groups and this was verified in the different phases of the nycthemere (Figure 2B and C). Overall, these results suggest that PARP-1 gene deletion may improve baroreflex sensitivity at early stages of the disease and that HF diet reverses the beneficial effects of PARP-1 deletion on baroreflex function.
###end p 27
###begin title 28
PARP-1 gene deletion improves spontaneous baroreflex sensitivity(SBRS).
###end title 28
###begin p 29
###xml 472 473 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 505 508 503 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
Data from telemetry recordings (average of 3 consecutive days) show restoration of SBRS by PARP-1 gene deletion in mouse model of atherosclerosis (A). Imroved SBRS response was not associated with significant difference in average HR (B) or MAP (C) during day or night among these groups. This effect was however abolished after feeding HF diet for 16 weeks (A). The data is expressed as mean +/- SEM from at least 6 mice in each group for 3 different set of experiments. P value (<0.05) *compared to ApoE-/- RD and double daggercompared to DKO mice on RD.
###end p 29
###begin title 30
PARP-1 Gene Deletion Improves HR Responses Following Selective Blockade of the Autonomic Nervous System
###end title 30
###begin p 31
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 207 216 207 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g003">Figure 3A</xref>
###xml 350 353 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 440 443 440 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 689 692 686 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 792 801 789 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g003">Figure 3B</xref>
###xml 921 924 918 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1335 1344 1332 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g003">Figure 3B</xref>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
###xml 760 765 <span type="species:ncbi:10090">mouse</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
###xml 925 929 <span type="species:ncbi:10090">mice</span>
###xml 935 939 <span type="species:ncbi:10090">mice</span>
Blockade of the parasympathetic drive by atropine (1 mg/kg) resulted in similar tachycardic responses in both wild type (WT) and ApoE-/- mice on RD, suggesting that vagal tone is not impaired in this group (Figure 3A). However, this increase in HR in response to atropine was significantly higher in DKO mice maintained on a regular diet than in ApoE-/- mice on a similar diet regimen. HF diet similarly reduced parasympathetic tone in ApoE-/- and DKO mice, again showing that the beneficial effect of PARP-1 gene deletion is reversed by HF diet. Blockade of sympathetic tone by propranolol (8 mg/kg), a non-specific beta-blocker, resulted in higher bradycardic in WT mice compared to ApoE-/- mice on RD suggesting that sympathetic tone is exacerbated in this mouse model of atherosclerosis (Figure 3B). This impairment was reversed in DKO mice fed RD. 16-week HF-diet regimen further exacerbated sympathetic tone in ApoE-/- mice; DKO mice remain protected against increased sympathetic tone. To exclude the possibility that the beneficial effects of PARP-1 gene deletion on HR responses, following atropine or propranolol administration, were due to genetic alterations of cardiac function, a ganglionic blocker (hexamethonium; 20 mg/kg i.p.), was administered and intrinsic HR between the different groups was evaluated. As shown in Figure 3B, when complete autonomic outflow was attenuated, the intrinsic HR was comparable between the groups, showing that the alterations observed in response to atropine or propranolol were not due to changes in cardiac rhythm, but reflected significant alterations of autonomic function.
###end p 31
###begin title 32
Loss of PARP-1 preserves autonomic and endothelial functions.
###end title 32
###begin p 33
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 269 272 269 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 567 570 567 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 658 661 658 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 862 863 862 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 895 898 895 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 925 928 920 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
###xml 698 702 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
###xml 977 981 <span type="species:ncbi:10090">mice</span>
(A). In response to atropine (parasympathetic tone blockade; 1 mg/kg), tachycardia was higher in DKO mice on RD than ApoE-/-, but high-fat diet abolished this effect. propranolol (sympathetic tone blockade; 8 mg/kg), induced higher bradycardic response in DKO than ApoE-/- and high-fat diet did not abolish this effect, Intrinsic HR determined following hexamethonium treatment (ganglionic blockade; 20 mg/kg i.p.) was comparable among these groups (B). Increase in MAP after acetylcholine (endothelium dependent vasodilator; 2 mg/kg) in DKO mice was higher than ApoE-/- mice (3C). In response to SNP, endothelium independent vasodilation was similar in ApoE-/- and WT mice, it was improved in DKO mice. Interestingly, although HF diet further impaired the ability of the vessels to relax, endothelium independent vasodilation was totally preserved in DKO mice. P value (<0.05) *compared to ApoE-/- RD, daggercompared to ApoE-/- HF (16 weeks), and double daggercompared to DKO mice on RD.
###end p 33
###begin title 34
PARP-1 Gene Deletion Prevents Dyslipidemia-Induced Endothelial Dysfunction
###end title 34
###begin p 35
###xml 286 295 286 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g003">Figure 3C</xref>
###xml 428 431 428 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 740 743 740 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 569 574 <span type="species:ncbi:10090">mouse</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
In order to establish the role of PARP-1 in endothelial dysfunction in conscious mice, the present study determined whether PARP-1 gene deletion provides protection against endothelium-dependent (acetylcholine; ACh) and independent (sodium nitroprusside; SNP) vasodilators. As shown in Figure 3C, both drugs lowered MAP in mice fed a RD. However, ACh-induced MAP reduction was significantly improved in DKO mice compared to ApoE-/- mice, suggesting that endothelium-dependent vasodilation was preserved in these mice. After feeding a HF diet regimen for 16 weeks, both mouse strains exhibited similar impairments of endothelium-dependent vasodilation in response to ACh. Again, while endothelium independent vasodilation was similar in ApoE-/- and WT mice on RD, it was significantly enhanced in DKO mice. Interestingly, although HF diet further impaired the ability of the vessels to relax, endothelium independent vasodilation was totally preserved in DKO mice. This further suggests that PARP-1 gene deletion is protective against endothelium-dependent dysfunction.
###end p 35
###begin title 36
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
PARP-1 gene deletion ameliorates the atherogenic index of high fat diet fed-ApoE-/- mice
###end title 36
###begin p 37
###xml 111 119 111 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g004">Figure 4</xref>
###xml 195 198 195 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 229 237 229 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g004">Figure 4</xref>
###xml 336 339 336 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Takasaki1">[31]</xref>
###xml 635 638 635 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 949 957 949 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g004">Figure 4</xref>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
Lipid profile data showed that DKO mice on RD exhibited moderately higher levels of LDL and total cholesterol (Figure 4). HDL-cholesterol in DKO mice on RD was markedly higher as compared to ApoE-/- mice on similar diet regimen (Figure 4). As expected, a 16 weeks HF diet regimen dramatically increased total and LDL-cholesterol in ApoE-/- mice. However, such an elevation in total and LDL-cholesterol was less pronounced in DKO mice. Atherogenic index is increasingly regarded as a more reasonable parameter of dyslipidemia rather than individual cholesterols [31]. In our study, the atherogenic index was significantly higher in ApoE-/- than in DKO mice on RD as well as in response to HF diet for 16 weeks. These results suggest that dyslipidemia may be partly responsible for vascular and autonomic dysfunctions and that protective effects of PARP-1 inhibition on these abnormalities may be mediated partly through its effects on lipid profile (Figure 4).
###end p 37
###begin title 38
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
PARP-1 inhibition decreases atherogenic index in ApoE-/- mice on HF diet for 16 weeks.
###end title 38
###begin p 39
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 267 270 267 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 364 367 364 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 539 542 539 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 563 572 563 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g002">Figure 2D</xref>
###xml 682 683 680 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 727 730 725 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 757 760 750 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 828 832 809 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d&#8722;/&#8722;</sup>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 557 561 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
Lipid profile data of 4 h starved mice shows that PARP-1 inhibition significantly increased HDL-cholesterol and total cholesterol in ApoE-/- mice on regular diet (4A and 4C). After feeding HF diet for 16 weeks, total and LDL-cholesterol increased dramatically in ApoE-/- mice. The increase in total and LDL cholesterol in DKO mice was significantly lower than ApoE-/- mice on similar diet regimen (4A and 4B). Though HF diet significantly decreased HDL-cholesterol in DKO mice, atherogenic index still remained significantly higher in ApoE-/- mice than DKO mice (Figure 2D). The data is expressed as mean+/-SEM from at least 6 mice in each group for 3 different set of experiments. P value (<0.05) *compared to age matched ApoE-/- RD, daggercompared to ApoE-/- HF (16 weeks), and double daggercompared to age matched ApoE-PARP-1d-/- mice on a regular diet.
###end p 39
###begin title 40
Loss of PARP-1 Preserves eNOS Activity without Altering Total eNOS Expression
###end title 40
###begin p 41
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 372 384 372 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g005">Figure 5A, B</xref>
###xml 471 474 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 518 530 518 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g005">Figure 5C, D</xref>
###xml 637 646 637 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g005">Figure 5E</xref>
###xml 714 723 714 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007430.s001">Figure S1</xref>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
In ApoE-/- mice, impaired responses to ACh could be due to an alteration in either eNOS expression or eNOS activation (eNOS phosphorylation). Immunohistochemical analysis of unmodified or phosphorylated eNOS in cardiac tissue isolated from the different experimental groups revealed that total eNOS expression was not altered when mice were maintained on a RD or HF diet (Figure 5A, B). However, phospho-eNOS immunoreactivity was significantly greater in DKO than in ApoE-/- mice, following either regular or HF diet (Figure 5C, D). These observations were confirmed by immunoblot analysis of cardiac extracts using the same antibodies (Figure 5E) and by RT PCR on cDNA prepared from left ventricle of these mice (Figure S1).
###end p 41
###begin title 42
Lack of PARP-1-mediated protection against endothelium dysfunction is associated with increased eNOS activity.
###end title 42
###begin p 43
###xml 0 16 0 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g005">Figures 5A and C</xref>
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 158 167 158 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g005">Figures 5</xref>
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 508 509 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 541 544 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 571 574 562 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
Figures 5A and C show IHC data with antibodies to eNOS or phospho-eNOS respectively of heart from ApoE-/- and DKO mice on a regular or high-fat for 16 weeks. Figures 5 B and D represent quantitation of immunoreactivity, performed using Image-Pro Plus software and expressed as immunoreactivity/mm2. (E) Western Blot of left ventricles isolated from these experimental groups (n = 6) were collected and subjected to protein extraction and western blotted for phopho-eNOS, or total eNOS. Scale bar: 50 microm. P value (<0.05) *compared to ApoE-/- RD, daggercompared to ApoE-/- HF (16 weeks), and double daggercompared to DKO mice on RD.
###end p 43
###begin title 44
###xml 79 82 79 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 83 87 <span type="species:ncbi:10090">Mice</span>
PARP-1 Gene Deletion Reduces Protein Nitration in Cardiac Tissue of HF-fed ApoE-/- Mice
###end title 44
###begin p 45
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 235 238 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 260 269 260 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g006">Figure 6A</xref>
###xml 479 491 479 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g006">Figures 6B&amp;C</xref>
###xml 646 658 646 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g006">Figures 6D&amp;E</xref>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
Cardiac tissue from the HF diet-fed ApoE-/- mice exhibited a high poly-ADP-ribose (PAR) immunoreactivity, indicating that PARP-1 activity was elevated in these mice, while a significantly lower PAR immunoreactivity was detected in ApoE-/- mice receiving a RD (Figure 6A). No PAR immunoreactivity was detected in cardiac tissue prepared from HF or RD-fed DKO mice. PARP-1 activation was mirrored by an increase in protein nitration as assessed by nitro-tyrosine immunoreactivity (Figures 6B&C), establishing a potential association between PARP-1 activation and oxidative stress. Protein nitration was decreased in tissue of HF diet-fed DKO mice (Figures 6D&E).
###end p 45
###begin title 46
PARP-1 gene deletion-induced protection of endothelial dysfunction is associated with reduction in the expression of nitrotyrosine and iNOS in heart.
###end title 46
###begin p 47
###xml 159 175 159 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007430-g006">Figures 6C and E</xref>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 324 325 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 357 360 353 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 387 390 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
Heart isolated from these experimental groups were collected and subjected to immunohistochemistry with antibodies to PAR (A), nitrotyrosine (B) and iNOS (C). Figures 6C and E represent quantitation of immunoreactivity was conducted using Image-Pro Plus software and expressed as immunoreactivity/mm2. Scale bar: 50 microm. P value (<0.05) *compared to ApoE-/- RD, daggercompared to ApoE-/- HF (16 weeks), and double daggercompared to DKO mice on RD.
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OumounaBenachour1">[15]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Hans1">[16]</xref>
###xml 537 549 <span type="species:ncbi:9606">participants</span>
The results of the present investigation demonstrate that PARP-1 participates in dyslipidemia-mediated vascular dysfunction and dysregulation of autonomic function and that PARP-1 gene deletion is protective against these defects. Previously, our laboratory demonstrated that PARP-1 inhibition affects atherosclerotic plaque dynamics and these alterations are highly desirable for the control of plaque progression and promotion of stability [15], [16]. Dynamics of atherogenesis are confined to atherosclerotic plaques but are integral participants of overall vascular dysfunction including hypertension, myocardial infarction and heart failure. The present study is a direct continuation of our ongoing investigation of the role of PARP-1 in atherosclerosis and associated pathologies.
###end p 49
###begin p 50
Alterations in central nervous system control of BP and HR are primary outcomes of dyslipidemia. Thus, devising strategies that can diminish or completely block the manifestation of these outcomes is of great clinical importance. In this study, we demonstrate that PARP-1 plays an important role in both dyslipidemia-associated vascular and autonomic dysfunction. Inhibition of this enzyme by gene knockout partially improved baroreflex sensitivity, without affecting baseline hemodynamic parameters, and improved autonomic function. It also prevented dyslipidemia-induced endothelial dysfunction, possibly through maintenance of eNOS activity. Moreover, modulation of oxidative tissue damage may underlie the observed protective effects of PARP-1 gene knockout.
###end p 50
###begin p 51
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Stauss1">[32]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Nasr1">[33]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Stauss1">[32]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Nasr1">[33]</xref>
###xml 601 605 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Nasr1">[33]</xref>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Lazartigues1">[30]</xref>
###xml 936 939 936 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1081 1085 1081 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Campos1">[34]</xref>
###xml 1220 1224 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Tank1">[35]</xref>
###xml 344 350 <span type="species:ncbi:9606">humans</span>
###xml 442 447 <span type="species:ncbi:9606">human</span>
###xml 448 456 <span type="species:ncbi:9606">patients</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
###xml 991 997 <span type="species:ncbi:9606">humans</span>
###xml 1034 1038 <span type="species:ncbi:10090">mice</span>
###xml 1445 1449 <span type="species:ncbi:10090">mice</span>
The arterial baroreceptor reflex is a classic negative feedback mechanism that is critical for maintaining BP around a setpoint by sensing its fluctuations and correcting accordingly [32], [33]. In recent years, a great deal of evidence has accumulated that supports the ability of dyslipidemia and its associated pathologies to impair SBRS in humans [32], [33]. In fact, Nasr et al. recently showed that bilateral carotid atherosclerosis in human patients is associated with an impairment of SBRS and a shift of the sympathovagal balance toward a decrease in parasympathetic-associated HR variability[33]. Many of these changes are clearly associated with elevated oxidative stress. Our laboratory previously reported that oxidative stress contributes to autonomic dysregulation in hypertensive and hypercholesterolemic mice[30]. The negative effect of dyslipidemia on SBRS observed is consistent with our previous studies done in ApoE-/- mice, with the effects of dyslipidemia observed in humans as well as in LDL-receptor knockout mice, as very recently reported by Campos et al[34]. It is noteworthy that changes in SBRS regulation may be mainly mediated by parasympathetic tone, an idea also set forth by Tank et al[35]. Furthermore, the parasympathetic tone seems more sensitive to dyslipidemia than sympathetic tone. A rather important and interesting finding in this study is that PARP-1 gene deletion preserved SBRS in regular diet-fed mice, but this protective effect was completely abolished in HF diet-fed animals. The mechanism through which a HF diet overwhelms the protective effect of PARP-1 gene deletion is unknown.
###end p 51
###begin p 52
###xml 227 230 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Rose1">[36]</xref>
###xml 586 589 586 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 982 986 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Kovacs1">[37]</xref>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 1085 1096 <span type="species:ncbi:9606">participant</span>
PARP-1 gene deletion preserved parasympathetic tone in RD-fed mice, but failed to do so in mice fed a HF diet. Conversely, PARP-1 deficiency significantly prevented exacerbated sympathetic tone not only in regular diet-fed ApoE-/- mice, but also in HF diet-fed animals. The reason(s) for the ability of DKO mice to maintain these responses during a regular diet regimen is unclear, and the reason(s) for their ability to maintain parasympathetic tone responses during a high-fat diet is even more puzzling. These discrepancies are not unprecedented, as Rose et al[36] reported that PI3K-/- mice displayed similar responses, which were attributed to negative regulation of cAMP by PI3K in the ventricular myocardium. Whether PARP-1 deficiency may affect the autonomic nervous system through a mechanism involving PI3K activity and cAMP is unknown, although poly(ADP-ribosyl)ation of the PI3K family member, DNA-dependent protein kinase, has been shown to enhance its kinase activity [37]. However, as eluded to earlier, oxidative stress has become increasingly regarded as an important participant in vascular impairments. Therefore, PARP-1 gene deletion may preserve cardiovascular function by modulating factors that instate oxidative stress. Inhibition of iNOS overexpression and subsequent nitrergic damage may be one such example.
###end p 52
###begin p 53
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-vonLukowicz1">[18]</xref>
###xml 457 460 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 884 888 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Takasaki1">[31]</xref>
###xml 1271 1275 1271 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Grassi1">[38]</xref>
###xml 1277 1281 1277 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OConnell1">[39]</xref>
###xml 1287 1290 1287 1290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1283 1387 1283 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE<sup>&#8722;/&#8722;</sup> mice can develop atherosclerotic lesions while on a regular diet but require a lengthy duration </italic>
###xml 1388 1390 1388 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">40</italic>
###xml 1387 1391 1387 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Crauwels2">[<italic>40</italic>]</xref>
###xml 1391 1727 1391 1727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">. In fact, complicated and multilayered plaques lesions such as those observed in humans require near or more than a year to take place. However, it remains rather interesting and important to assess the effect of long term regular diet on the deterioration of autonomic and vascular functions and protective effects by PARP inhibition.</italic>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 1291 1295 <span type="species:ncbi:10090">mice</span>
###xml 1473 1479 <span type="species:ncbi:9606">humans</span>
Our data suggests that though PARP-1 gene deletion moderately increased total cholesterol levels on regular diet regimen, but HF diet induced higher total and LDL- cholesterol in ApoE-/- mice than DKO mice. Moreover, PARP-1 gene deletion significantly increased HDL-cholesterol, an effect which was abolished by HF diet. Interestingly, von Lukowicz et al[18] reported significantly higher levels of total and LDL- cholesterol in DKO mice as compared to ApoE-/- mice which is in contrast to our data. However, in their study, they used 1.25% total cholesterol in their diet which is 6 times higher than HF diet used in our studies (0.2% cholesterol). Further mice used in our study are from homogenous background (C57BL/6J). Atherogenic index, which has been suggested as better index of dyslipidemia and important tool to analyze the results considering the complexity of lipoproteins[31] was significantly decreased by PARP-1 gene deletion in both RD and HF regimen. Interestingly PARP-1 gene deletion increased HDL by double in regular diet group, an effect which was abolished by HF diet. Though mechanism of increased HDL levels by PARP-1 gene deletion is unknown, HDL- cholesterol has independently been reported to correlate with autonomic and vascular dysfunctions[38], [39]. ApoE-/- mice can develop atherosclerotic lesions while on a regular diet but require a lengthy duration [40]. In fact, complicated and multilayered plaques lesions such as those observed in humans require near or more than a year to take place. However, it remains rather interesting and important to assess the effect of long term regular diet on the deterioration of autonomic and vascular functions and protective effects by PARP inhibition.
###end p 53
###begin p 54
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Aktan1">[41]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Naura1">[42]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-OumounaBenachour1">[15]</xref>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Hans1">[16]</xref>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Pacher1">[19]</xref>
###xml 598 602 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Naura2">[43]</xref>
###xml 675 679 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Naura1">[42]</xref>
###xml 795 799 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Manea1">[44]</xref>
###xml 763 768 <span type="species:ncbi:9606">human</span>
Many studies, including those from our laboratory, have shown that PARP-1 inhibition greatly reduces expression of iNOS[41], [42]. Several groups, including ours, have demonstrated the responsiveness of PARP-1 to oxidative stress and its participation in oxidative stress-associated endothelial and cardiac dysfunctions [15], [16], [19]. In fact, our laboratory recently demonstrated that a more complex relationship between PARP-1 and iNOS exists, as these two proteins are reciprocally regulated during airway inflammation with NF-kappaB activation serving as major component of this relationship[43]. Notably, NF-kappaB regulates the expression of iNOS during inflammation[42]. NF-kappaB has also been suggested to regulate NADPH oxidase subunit p22 (phox) in human aortic smooth muscle cells[44]. Therefore, PARP-1 deficiency may exert an antioxidant effect and maintain autonomic nervous system through a direct effect on NAD(P)H oxidase complex function. Obviously, this hypothesis needs to be confirmed through additional experimentation.
###end p 54
###begin p 55
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Gava1">[45]</xref>
###xml 381 382 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 443 444 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Godecke1">[46]</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Godecke1">[46]</xref>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Pacher3">[47]</xref>
Endothelial NOS (eNOS) activity is thought to have an important influence on the activity of the sympathetic tone[45]. Pathological processes that reduce vascular NO may do so through down regulation of eNOS expression or inhibition of eNOS activity. They may also reduce vascular NO by decreasing NO bioavailability, an effect attributable to NO inactivation by radicals such as O2-, which generates the noxious byproduct, peroxynitrite (ONOO-)[46]. Thus, increased oxidative stress in the vascular wall is a key mechanism underlying endothelial dysfunction[46]. The increased levels of protein nitration in cardiac tissues of HF diet-fed animals is evidence for increased levels of ONOO-, which would be suggestive of a decrease in NO bioavailability and may explain the observed endothelial dysfunction in these animals[47]. Therefore, it is tempting to speculate that the ability of PARP-1 deficiency to prevent such extensive oxidative stress and to maintain eNOS activity underlies protection against endothelial dysfunction and dysregulated autonomic nervous system.
###end p 55
###begin p 56
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Pacher1">[19]</xref>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007430-Gero1">[23]</xref>
Numerous studies of PARP-1 involvement in oxidative stress-associated endothelial dysfunction, primarily using cell culture and ex vivo systems, have demonstrated that pharmacological inhibition of PARP-1 confers protection against such dysfunction (for review[19], [23]).
###end p 56
###begin p 57
In conclusion, using conscious animals we have demonstrated that PARP-1 participates in dyslipidemia-mediated vascular dysfunction and dysregulation of autonomic function and that PARP-1 gene deletion is protective against these defects. Future studies may better clarify the mechanism by which PARP-1 participates in autonomic nervous system function.
###end p 57
###begin title 58
Supporting Information
###end title 58
###begin p 59
###xml 289 310 289 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
RT PCR shows similar eNOS expression in heart or aorta of ApoE-/- mice and DKO mice suggesting that PARP-1 inhibition is affecting activation (phosphor-eNOS) rather than amount of eNOS. cDNA generated from the heart or aorta extract was subjected to PCR using the primers described in the Materials and Methods generating a single PCR product.
###end p 59
###begin p 60
(0.06 MB TIF)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
We thank Dr. Kurt Varner for providing with additional telemetry probes and Dr. Daniel Kapusta for critically reading the manuscript. We also thank Dr. Lisa Harrison-Bernard for her help with quantification of immunoreactivity.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
Atherosclerosis: Disease Biology Affecting the Coronary Vasculature.
###end article-title 64
###begin article-title 65
Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis.
###end article-title 65
###begin article-title 66
Physical Fitness and the Relationship Between Hypertension and Markers of Atherothrombosis.
###end article-title 66
###begin article-title 67
Central nervous system regulation of cardiovascular homeostasis.
###end article-title 67
###begin article-title 68
Baroreflex Sensitivity: Measurement and Clinical Implications.
###end article-title 68
###begin article-title 69
###xml 150 154 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Enhanced sympathetic outflow and decreased baroreflex sensitivity are associated with intermittent hypoxia-induced systemic hypertension in conscious rats.
###end article-title 69
###begin article-title 70
The sympathetic control of blood pressure.
###end article-title 70
###begin article-title 71
Nitric Oxide, Atherosclerosis and the Clinical Relevance of Endothelial Dysfunction.
###end article-title 71
###begin article-title 72
eNOS phosphorylation: A pivotal molecular switch in vasodilation and cardioprotection?
###end article-title 72
###begin article-title 73
Understanding eNOS for pharmacological modulation of endothelial function: a translational view.
###end article-title 73
###begin article-title 74
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.
###end article-title 74
###begin article-title 75
Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis.
###end article-title 75
###begin article-title 76
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI.
###end article-title 76
###begin article-title 77
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
Endothelium-targeted transgenic GTP-cyclohydrolase I overexpression inhibits neointima formation in mouse carotid artery.
###end article-title 77
###begin article-title 78
###xml 146 150 <span type="species:ncbi:10090">mice</span>
Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
###end article-title 78
###begin article-title 79
Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability.
###end article-title 79
###begin article-title 80
###xml 167 171 <span type="species:ncbi:10090">mice</span>
Thieno[2,3-c]isoquinolin-5-one (TIQ-A), a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high fat diet-fed ApoE-deficient mice: effects on inflammatory markers and lipid content.
###end article-title 80
###begin article-title 81
PARP1 is required for adhesion molecule expression in atherogenesis.
###end article-title 81
###begin article-title 82
Role of Poly(ADP-ribose) polymerase 1 (PARP-1) in Cardiovascular Diseases: The Therapeutic Potential of PARP Inhibitors.
###end article-title 82
###begin article-title 83
A New, Potent Poly(ADP-ribose) Polymerase Inhibitor Improves Cardiac and Vascular Dysfunction Associated with Advanced Aging.
###end article-title 83
###begin article-title 84
Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase.
###end article-title 84
###begin article-title 85
Poly(ADP-Ribose) Polymerase Is Activated in Subjects at Risk of Developing Type 2 Diabetes and Is Associated With Impaired Vascular Reactivity.
###end article-title 85
###begin article-title 86
Poly(ADP-ribose) polymerase: a new therapeutic target?
###end article-title 86
###begin article-title 87
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase.
###end article-title 87
###begin article-title 88
###xml 83 89 <span type="species:ncbi:10090">Murine</span>
PARP-1 Inhibition Prevents eosinophil recruitment by Modulating Th2 Cytokines in a Murine Model of Allergic Airway Inflammation: a Potential Specific Effect on IL-5.
###end article-title 88
###begin article-title 89
Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II-Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor Downregulation.
###end article-title 89
###begin article-title 90
###xml 105 111 <span type="species:ncbi:9606">humans</span>
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra- arterial blood pressure monitoring in humans.
###end article-title 90
###begin article-title 91
###xml 151 155 <span type="species:ncbi:10090">mice</span>
Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice.
###end article-title 91
###begin article-title 92
DITPA stimulates arteriolar growth and modifies myocardial postinfarction remodeling.
###end article-title 92
###begin article-title 93
###xml 147 151 <span type="species:ncbi:10090">mice</span>
Oxidative stress contributes to increased sympathetic vasomotor tone and decreased baroreflex sensitivity in hypertensive and hypercholesterolemic mice.
###end article-title 93
###begin article-title 94
###xml 71 79 <span type="species:ncbi:9606">Children</span>
Serum Lipid Levels and Factors Affecting Atherogenic Index in Japanese Children.
###end article-title 94
###begin article-title 95
###xml 83 87 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Baroreceptor reflex sensitivity estimated by the sequence technique is reliable in rats.
###end article-title 95
###begin article-title 96
Baroreflex Sensitivity Is Impaired in Bilateral Carotid Atherosclerosis.
###end article-title 96
###begin article-title 97
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Baroreflex sensitivity and oxidative stress in the LDL receptor knockout mice.
###end article-title 97
###begin article-title 98
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Clonidine improves spontaneous baroreflex sensitivity in conscious mice through parasympathetic activation.
###end article-title 98
###begin article-title 99
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Altered heart rate and sinoatrial node function in mice lacking the cAMP regulator phosphoinositide 3-kinase-gamma.
###end article-title 99
###begin article-title 100
Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
###end article-title 100
###begin article-title 101
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.
###end article-title 101
###begin article-title 102
High-Density Lipoproteins and Endothelial Function.
###end article-title 102
###begin article-title 103
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI.
###end article-title 103
###begin article-title 104
iNOS-mediated nitric oxide production and its regulation.
###end article-title 104
###begin article-title 105
Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia.
###end article-title 105
###begin article-title 106
Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia.
###end article-title 106
###begin article-title 107
###xml 58 63 <span type="species:ncbi:9606">human</span>
Regulation of NADPH oxidase subunit p22(phox) by NF-kB in human aortic smooth muscle cells.
###end article-title 107
###begin article-title 108
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Overexpression of eNOS prevents the development of renovascular hypertension in mice.
###end article-title 108
###begin article-title 109
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Endothelial dysfunction of coronary resistance vessels in apoE-/- mice involves NO but not prostacyclin-dependent mechanisms.
###end article-title 109
###begin article-title 110
Nitric oxide and peroxynitrite in health and disease.
###end article-title 110
###begin p 111
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 111
###begin p 112
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: National Institutes of Health HL072889 and 1P20RR18766 (overall Principal Investigator, D. Kapusta) to A.H.B; American Heart Association Postdoctoral fellowship to C.P.H (0825470E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 112

